Press release – Biofina Diagnostics S.L has been awarded with a Seal of Excellence by the European Commission
Biofina Diagnostics S.L has been awarded with a Seal of Excellence by the European Commission following the presentation of its project proposal UROBEST ´UROthelial carcinoma Biomarker based diagnostic tEST´ Submitted under the Horizon 2020’s SME instrument phase 2 call H2020-SMEInst-2014-2015 (H2020-SMEINST-2-2015) of 25 November 2015 in the area of Clinical research for the validation of biomarkers and/or diagnostic medical devices. [...]
Dra. Mª José Ribal speaks about bladder cancer biomarkers in the 7th European Multidisciplinary Meeting on Urological Cancers (EMUC) in Barcelona
Dr. Alcaraz and Dra. Ribal are included in the Top Doctors portal (www.topdoctors.es), a tool to find the top-tier Specialists in each medical discipline. Both are included as first level professional in the urologist practice, in particular bladder cancer management. http://www.topdoctors.es/doctor/antonio-alcaraz-asensio http://www.topdoctors.es/doctor/maria-jose-ribal-caparros
Genomic aproaches to the analysis of urine non-invasive diagnosis appear to be approaching the sensitivities and specificities required to be viable alternatives to flexible cystoscopy.
The Urology team from the Hospital Clinic of Barcelona, led by Dr. Antonio Alcaraz, presented the poster “Clinical validation of a gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter study” in the 2015 European Association of Urology meeting.